Anokion
PrivateLast Round
Corporate Funding
Oct 18, 2022
Total Funding Raised
$112.5M
Company Overview
Anokion operates in Healthcare & Life Sciences and is based in Ecublens. Its latest recorded funding round was a Corporate Funding round in October 2022.
Anokion is a biotechnology company that develops antigen-specific immunotherapy aimed at promoting immune tolerance for various autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anokion Comparables
Compare Anokion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Parvus Therapeutics Inc. | 87% | |
| Worg Pharmaceuticals | 83% | |
| AnTolRx, Inc. | 83% |
For institutional investors. Book with your work email.
Anokion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Oct 18, 2022 | ||||
| Series B | Sep 11, 2019 | ||||
| Series A | May 5, 2014 |
For institutional investors. Book with your work email.
Anokion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Ventures | Series B, Series A |
| Versant Ventures | Series B, Series A |
| Novo Holdings | Series B, Series A |
| Pfizer | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2014
$38M round led by Novartis and Versant Ventures.
For institutional investors. Book with your work email.
Anokion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anokion's valuation, stock price, and market status.
Is Anokion a public or private company?
Anokion is a private company.
What is the current stock price of Anokion?
Anokion is a private company, so its shares have no public market price. Caplight tracks Anokion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anokion worth (valuation)?
Valuation information for Anokion is not publicly available.
Can I buy Anokion stock?
Anokion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anokion's last funding round?
Anokion's most recent funding round was Corporate Funding on October 18, 2022.
Who are the main investors in Anokion?
Key investors in Anokion include Novo Ventures, Versant Ventures, Pfizer.
Will Anokion IPO soon?
No public IPO plans have been announced for Anokion.
How can I track Anokion secondary market activity?
Caplight tracks bids, offers, and trades in Anokion's shares on secondary markets.